REPro pairs rigorous mixed-methods research with client-ready dashboards and briefs, for health systems, Medicaid agencies, and innovators working in maternal, reproductive, and family health.
REPro works in one place, across four connected topics.
Pregnancy, birth, and the postpartum year — including the policy that shapes outcomes in it.
Access, autonomy, and the systems that determine who gets care, and when.
Outcomes that extend past the parent to the family unit they return home to.
Who bears risk unequally in this data, and what a policy or program could close.
One gets a client-ready dashboard in front of your team quickly. The other goes deeper, when a program or policy decision needs a fuller evidence base.
We take your claims, encounter, or program data and turn it into a client-ready dashboard and decision brief — built to sit in front of a board, a state legislature, or a funder, not a shared drive.
Deeper qualitative and evaluative work for organizations building or assessing a maternal health program — from a new virtual care model to a state policy pilot.
Most Data-to-Decision engagements are scoped and priced per project — typically 4–8 weeks, not billed hourly. Research & Evaluation engagements are scoped individually based on methods and timeline.
A sample built the same way a client engagement would be — from public maternal health data to a board-ready brief.
We talk through the decision you're trying to make and what data you already have.
You get a written scope, timeline, and price before anything starts.
Data cleaning, analysis, and dashboard or brief development, with check-ins along the way.
You get the finished deliverable, plus a working session to walk through findings and next steps.
REPro can execute a Business Associate Agreement for any engagement that involves protected health information.
Data is used only for the scoped analysis it was provided for — never repurposed, sold, or shared beyond the engagement.
Files are transferred and stored securely, and returned or deleted once the engagement closes.
Comfortable in Medicaid claims data, state legislative language, and the CDC and KFF literature that shapes this field — so findings arrive in terms your stakeholders already use.
Every deliverable is scoped to the choice it needs to inform, not a general-purpose report that gets filed away unread.
Qualitative and quantitative evidence are combined from the start, not run in parallel and left for your team to reconcile.
"Reproductive health disparities persist because too many policies are built without the evidence to close them. I founded REPro to change that — pairing rigorous data analysis with a relentless focus on the outcomes that matter for women and families."
— Molly Waymouth
Molly Waymouth is a health policy researcher and analyst whose work focuses on evaluating innovative, technology-enabled care models and policy structures to advance health equity and dismantle barriers to care for underserved populations. Her research centers on maternal, perinatal, and women's health, with extensive expertise spanning randomized clinical trial design, implementation science, and macro-level societal impact modeling.
Her scholarship bridges mixed-methods clinical evaluation — such as assessing the equity, acceptability, and clinical outcomes of telelactation, virtual doula care, and remote monitoring programs — with high-level policy research examining the return on investment for women's health research funding and systemic access barriers across healthcare systems.
Selected track recordTell us what you're trying to decide, roughly when, and what data you have to work with — we'll follow up with a scope and a quote.
